Advocating for a world where intellectual
property law serves the public interest.
Two departments within India’s Ministry of Science and Technology, the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) have released a new Open Access Policy. Under the new policy, researchers who receive funding or use resources from from these departments can still publish in any journals they wish, but they will […]
In his visit to the G20 in Brisbane, President Barack Obama sought to promote his ambitious Pacific Rim trade agreement — the Trans-Pacific Partnership. He told an audience at the University of Queensland: We’ll keep leading the effort to realize the Trans-Pacific Partnership to lower barriers, open markets, export goods, and create good jobs for our people. […]
The name the Motion Picture Association of America used for its anti-Google campaign—“Project Goliath”—may be more self-revelatory than the MPAA expected. It has been widely reported that the hacked Sony Pictures emails reveal that in early 2014, MPAA launched Project Goliath, a policy initiative to develop legal tools to block access to websites that facilitate […]
Dear Mr. President: The organizations signing this letter want to express our deep concerns regarding some of the provisions under negotiation in the Trans Pacific Partnership (TPP). These provisions could seriously impact access to affordable medicines by delaying generic competition as well as impacting governments’ ability to advance public health policies in the U.S and […]
Multi-sectoral NGO coalition calls for greater protections for consumers, journalists, whistleblowers, researchers and workers Joint statement by 15 NGOs Link to PDF on Health Action International Site We strongly oppose the hasty push by the European Commission and Council for a new European Union (EU) directive on trade secrets[i] because it contains: An unreasonably broad […]
[Lawyers Collective press release, Link] In a momentous decision that would have wide-ranging implication for access to medicines, the Supreme Court of India refused to entertain Bayer’s appeal to set aside the compulsory license (CL) on Sorafenib (Nexavar). The Supreme Court’s dismissal of Bayer’s Special Leave Petition against the Bombay High Court’s decision upholding of […]
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources